Ben-Baruch A - Search Results

1

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A. Yaal-Hahoshen N, et al. Clin Cancer Res. 2006 Aug 1;12(15):4474-80. doi: 10.1158/1078-0432.CCR-06-0074. Clin Cancer Res. 2006. PMID: 16899591 Review.

2

Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A. Luboshits G, et al. Cancer Res. 1999 Sep 15;59(18):4681-7. Cancer Res. 1999. PMID: 10493525

3

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M, Wigler N, Keydar I, Ben-Baruch A. Azenshtein E, et al. Cancer Res. 2002 Feb 15;62(4):1093-102. Cancer Res. 2002. PMID: 11861388

4

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

Wigler N, Shina S, Kaplan O, Luboshits G, Chaitchik S, Keydar I, Ben-Baruch A. Wigler N, et al. Isr Med Assoc J. 2002 Nov;4(11 Suppl):940-3. Isr Med Assoc J. 2002. PMID: 12455185

5

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions.

Ben-Baruch A. Ben-Baruch A. Breast Cancer Res. 2003;5(1):31-6. doi: 10.1186/bcr554. Epub 2002 Oct 28. Breast Cancer Res. 2003. PMID: 12559043 Free PMC article. Review.

6

Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.

Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP. Neumark E, et al. Int J Cancer. 2003 Oct 10;106(6):879-86. doi: 10.1002/ijc.11337. Int J Cancer. 2003. PMID: 12918065

7

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.

Goldberg-Bittman L, Neumark E, Sagi-Assif O, Azenshtein E, Meshel T, Witz IP, Ben-Baruch A. Goldberg-Bittman L, et al. Immunol Lett. 2004 Mar 29;92(1-2):171-8. doi: 10.1016/j.imlet.2003.10.020. Immunol Lett. 2004. PMID: 15081542

8

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

Azenshtein E, Meshel T, Shina S, Barak N, Keydar I, Ben-Baruch A. Azenshtein E, et al. Cancer Lett. 2005 Jan 10;217(1):73-86. doi: 10.1016/j.canlet.2004.05.024. Cancer Lett. 2005. PMID: 15596298

9

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.

Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A. Zipin-Roitman A, et al. Cancer Res. 2007 Apr 1;67(7):3396-405. doi: 10.1158/0008-5472.CAN-06-3087. Cancer Res. 2007. PMID: 17409450

10

The inflammatory chemokines CCL2 and CCL5 in breast cancer.

Soria G, Ben-Baruch A. Soria G, et al. Cancer Lett. 2008 Aug 28;267(2):271-85. doi: 10.1016/j.canlet.2008.03.018. Epub 2008 Apr 24. Cancer Lett. 2008. PMID: 18439751 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters